Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$11.7

Avg closing price
Price range

2 Prem Watsa Trillium Therapeutics Trades

Prem Watsa started to build up the position in Trillium Therapeutics in Q3 2021. Since then they sold 341 Thousand shares. The investor sold all their shares in Q4 2021 and doesn't own any shares in Trillium Therapeutics anymore.

Avg closing price
Price range
Sold -341 Thousand shares Q4 2021
Avg closing price $17.82
Price range $17.50 - $18.44
New holding (+341 Thousand shares) Q3 2021
Avg closing price $11.68
Price range $5.86 - $17.80

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!